Impact of brief exercise on peripheral blood NK cell gene and microRNA expression in young adults

Journal of Applied Physiology

Volumn 114, Issue 5, 2013, Pages 628-636

  Radom Aizik, Shlomit ^a   Zaldivar, Frank ^a   Haddad, Fadia ^a   Cooper, Dan M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer; Epigenetic; Immune system; Leukocytes; MiRNA

Indexed keywords

CYTOKINE; LACTIC ACID; MICRORNA;

ADULT; ARTICLE; BLOOD; EXERCISE; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; LEUKOCYTE; MALE; METABOLISM; MONONUCLEAR CELL; NATURAL KILLER CELL; OXYGEN CONSUMPTION; PHYSIOLOGY; YOUNG ADULT;

ADULT; CYTOKINES; EXERCISE; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; LACTIC ACID; LEUKOCYTES; LEUKOCYTES, MONONUCLEAR; MALE; MICRORNAS; OXYGEN CONSUMPTION; YOUNG ADULT;

EID: 84878539302     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01341.2012     Document Type: Article

References (57)

1. Adams GR, Zaldivar FP, Nance DM, Kodesh E, Radom-Aizik S, Cooper DM. Exercise and leukocyte interchange among central circulation, lung, spleen, and muscle. Brain Behav Immun 25: 658-666, 2011.
2. Ben-Eliyahu S, Page GG, Schleifer SJ. Stress, NK cells, and cancer: Still a promissory note. Brain Behav Immun 21: 881-887, 2007.
3. Bernardini G, Gismondi A, Santoni A. Chemokines and NK cells: regulators of development, trafficking and functions. Immunol Lett 145: 39-46, 2012.
4. Bezman NA, Cedars E, Steiner DF, Blelloch R, Hesslein DG, Lanier LL. Distinct requirements of microRNAs in NK cell activation, survival, and function. J Immunol 185: 3835-3846, 2010.
5. Bezman NA, Chakraborty T, Bender T, Lanier LL. miR-150 regulates the development of NK and iNKT cells. J Exp Med 208: 2717-2731, 2011.
6. Bihl F, Germain C, Luci C, Braud VM. Mechanisms of NK cell activation: CD4(+) T cells enter the scene. Cell Mol Life Sci 68: 3457-3467, 2011.
7. Braun M, Muller B, ter Meer D, Raffegerst S, Simm B, Wilde S, Spranger S, Ellwart J, Mosetter B, Umansky L, Lerchl T, Schendel DJ, Falk CS. The CD6 scavenger receptor is differentially expressed on a CD56 natural killer cell subpopulation and contributes to natural killerderived cytokine and chemokine secretion. J Innate Immun 3: 420-434, 2011.
8. Buttner P, Mosig S, Lechtermann A, Funke H, Mooren FC. Exercise affects the gene expression profiles of human white blood cells. J Appl Physiol 102: 26-36, 2007.
9. Campoli M, Ferrone S. HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition. Semin Immunopathol 33: 321-334, 2011.
10. Carrega P, Pezzino G, Queirolo P, Bonaccorsi I, Falco M, Vita G, Pende D, Misefari A, Moretta A, Mingari MC, Moretta L, Ferlazzo G. Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells. PLos One 4: e8132, 2009.
11. Cichocki F, Felices M, McCullar V, Presnell SR, Al-Attar A, Lutz CT, Miller JS. Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling. J Immunol 187: 6171-6175, 2011.
12. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 22: 633-640, 2001.
13. Costill DL, Cote R, Fink W. Muscle water and electrolytes following varied levels of dehydration in man. J Appl Physiol 40: 6-11, 1976.
14. Cullen SP, Brunet M, Martin SJ. Granzymes in cancer and immunity. Cell Death Differ 17: 616-623, 2010.
15. Espinoza JL, Takami A, Yoshioka K, Nakata K, Sato T, Kasahara Y, Nakao S. Human microRNA-1245 downregulates the NKG2D receptor in NK cells and impairs NKG2D-mediated functions. Haematologica 97: 1295-1303, 2012.
16. Essmann F, Schulze-Osthoff K. Translational approaches targeting the p53 pathway for anti-cancer therapy. Br J Pharmacol 165: 328-344, 2012.
17. Finn OJ. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer. Ann Oncol 23, Suppl 8: viii6 -viii9, 2012.
18. Gong J, Liu R, Zhuang R, Zhang Y, Fang L, Xu Z, Jin L, Wang T, Song C, Yang K, Wei Y, Yang A, Jin B, Chen L. miR-30c-1* promotes natural killer cell cytotoxicity against human hepatoma cells by targeting the transcription factor HMBOX1. Cancer Sci 103: 645-652, 2012.
19. Gurovich AN, Braith RW. Analysis of both pulsatile and streamline blood flow patterns during aerobic and resistance exercise. Eur J Appl Physiol 112: 3755-3764, 2012.
20. Handschin C, Spiegelman BM. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 454: 463-469, 2008.
21. Hanna J, Bechtel P, Zhai Y, Youssef F, McLachlan K, Mandelboim O. Novel insights on human NK cells' immunological modalities revealed by gene expression profiling. J Immunol 173: 6547-6563, 2004.
22. Hatta K, Macleod RJ, Gerber SA, Croy BA. Emerging themes in uterine natural killer cell heterogeneity and function. Am J Reprod Immunol 68: 282-289, 2012.
23. Heath GW, Parra DC, Sarmiento OL, Andersen LB, Owen N, Goenka S, Montes F, Brownson RC. Evidence-based intervention in physical activity: lessons from around the world. Lancet 380: 272-281, 2012.
24. Huang dW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13, 2009.
25. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57, 2009.
26. Ishikawa E, Takano S, Ohno T, Tsuboi K. Adoptive cell transfer therapy for malignant gliomas. Adv Exp Med Biol 746: 109-120, 2012.
27. Khan AN, Magner WJ, Tomasi TB. An epigenetic vaccine model active in the prevention and treatment of melanoma. J Transl Med 5: 64, 2007.
28. Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M. microRNAs in cancer management. Lancet Oncol 13: e249-e258, 2012.
29. Krukowski K, Eddy J, Kosik KL, Konley T, Janusek LW, Mathews HL. Glucocorticoid dysregulation of natural killer cell function through epigenetic modification. Brain Behav Immun 25: 239-249, 2011.
30. Loprinzi PD, Cardinal BJ, Winters-Stone K, Smit E, Loprinzi CL. Physical activity and the risk of breast cancer recurrence: a literature review. Oncol Nurs Forum 39: 269-274, 2012.
31. Lundqvist A, Abrams SI, Schrump DS, Alvarez G, Suffredini D, Berg M, Childs R. Bortezomib and depsipeptide sensitize tumors to tumor necrosis factor-related apoptosis-inducing ligand: a novel method to potentiate natural killer cell tumor cytotoxicity. Cancer Res 66: 7317-7325, 2006.
32. Ma F, Xu S, Liu X, Zhang Q, Xu X, Liu M, Hua M, Li N, Yao H, Cao X. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-gamma. Nat Immunol 12: 861-869, 2011.
33. MacNeil B, Hoffman-Goetz L. Effect of exercise on natural cytotoxicity and pulmonary tumor metastases in mice. Med Sci Sports Exerc 25: 922-928, 1993.
34. Martorelli D, Muraro E, Merlo A, Turrini R, Fae DA, Rosato A, Dolcetti R. Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virusdriven disorders. Clin Dev Immunol 2012: 931952, 2012.
35. McQueen KL, Parham P. Variable receptors controlling activation and inhibition of NK cells. Curr Opin Immunol 14: 615-621, 2002.
36. Mori S, Jewett A, Cavalcanti M, Murakami-Mori K, Nakamura S, Bonavida B. Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-alpha and PMA/ionomycin. Int J Oncol 12: 1165-1170, 1998.
37. Neeman E, Ben-Eliyahu S. Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvement. Brain Behav Immun. In press.
38. Nice TJ, Coscoy L, Raulet DH. Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress. J Exp Med 206: 287-298, 2009.
39. Park KU, Jin P, Sabatino M, Feng J, Civini S, Khuu H, Berg M, Childs R, Stroncek D. Gene expression analysis of ex vivo expanded and freshly isolated NK cells from cancer patients. J Immunother 33: 945-955, 2010.
40. Perera PY, Lichy JH, Waldmann TA, Perera LP. The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use. Microbes Infect 14: 247-261, 2012.
41. Pham NM, Mizoue T, Tanaka K, Tsuji I, Tamakoshi A, Matsuo K, Ito H, Wakai K, Nagata C, Sasazuki S, Inoue M, Tsugane S. Physical activity and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 42: 2-13, 2012.
42. Radom-Aizik S, Zaldivar F Jr, Leu SY, Adams GR, Oliver S, Cooper DM. Effects of exercise on microRNA expression in young males peripheral blood mononuclear cells. Clin Transl Sci 5: 32-38, 2012.
43. Radom-Aizik S, Zaldivar F Jr, Leu SY, Cooper DM. A brief bout of exercise alters gene expression and distinct gene pathways in peripheral blood mononuclear cells of early-and late-pubertal females. J Appl Physiol 107: 168-175, 2009.
44. Radom-Aizik S, Zaldivar F Jr, Leu SY, Galassetti P, Cooper DM. Effects of 30 min of aerobic exercise on gene expression in human neutrophils. J Appl Physiol 104: 236-243, 2008.
45. Radom-Aizik S, Zaldivar F Jr, Oliver S, Galassetti P, Cooper DM. Evidence for microRNA involvement in exercise-associated neutrophil gene expression changes. J Appl Physiol 109: 252-261, 2010.
46. Shakhar G, Abudarham N, Melamed R, Schwartz Y, Rosenne E, Ben-Eliyahu S. Amelioration of operation-induced suppression of marginating pulmonary NK activity using poly IC: a potential approach to reduce postoperative metastasis. Ann Surg Oncol 14: 841-852, 2007.
47. Shinkai S, Shore S, Shek PN, Shephard RJ. Acute exercise and immune function. Relationship between lymphocyte activity and changes in subset counts. Int J Sports Med 13: 452-461, 1992.
48. Souza-Fonseca-Guimaraes F, Adib-Conquy M, Cavaillon JM. Natural killer (NK) cells in antibacterial innate immunity: angels or devils? Mol Med 18: 270-285, 2012.
49. Srivastava S, Lundqvist A, Childs RW. Natural killer cell immunotherapy for cancer: a new hope. Cytotherapy 10: 775-783, 2008.
50. Stewart IB, McKenzie DC. The human spleen during physiological stress. Sports Med 32: 361-369, 2002.
51. Takeda K, Nakayama M, Sakaki M, Hayakawa Y, Imawari M, Ogasawara K, Okumura K, Smyth MJ. IFN-gamma production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in mice. J Leukoc Biol 90: 777-785, 2011.
52. Tavri S, Jha P, Meier R, Henning TD, Muller T, Hostetter D, Knopp C, Johansson M, Reinhart V, Boddington S, Sista A, Wels WS, Daldrup-Link HE. Optical imaging of cellular immunotherapy against prostate cancer. Mol Imaging 8: 15-26, 2009.
53. Timmons BW, Cieslak T. Human natural killer cell subsets and acute exercise: a brief review. Exerc Immunol Rev 14: 8-23, 2008.
54. Timmons BW, Tarnopolsky MA, Bar-Or O. Sex-based effects on the distribution of NK cell subsets in response to exercise and carbohydrate intake in adolescents. J Appl Physiol 100: 1513-1519, 2006.
55. Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L. Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol 12: 239-252, 2012.
56. Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, Bishop NC, Fleshner M, Green C, Pedersen BK, Hoffman-Goetz L, Rogers CJ, Northoff H, Abbasi A, Simon P. Position statement. Part one: Immune function and exercise. Exerc Immunol Rev 17: 6-63, 2011.
57. Wendt K, Wilk E, Buyny S, Buer J, Schmidt RE, Jacobs R. Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells. J Leukoc Biol 80: 1529-1541, 2006.